Journal article icon

Journal article : Review

The PD-1/PD-L1 checkpoint in normal germinal centers and diffuse large B-cell lymphomas

Abstract:
Besides a recognized role of PD-1/PD-L1 checkpoint in anti-tumour immune evasion, there is accumulating evidence that PD-1/PD-L1 interactions between B and T cells also play an important role in normal germinal center (GC) reactions. Even when smaller in number, T follicular helper cells (TFH) and regulatory T (TFR) or B (Breg) cells are involved in positive selection of GC B cells and may result critical in the lymphoma microenvironment. Here, we discuss a role of PD-1/PD-L1 during tumour evolution in diffuse large B cell lymphoma (DLBCL), a paradigm of GC-derived lymphomagenesis. We depict a progression model, in two phases, where malignant B cells take advantage of positive selection signals derived from correct antigen-presentation and PD-1/PD-L1 inter-cellular crosstalks to survive and initiate tumour expansion. Later, a constant pressure for the accumulation of genetic/epigenetic alterations facilitates that DLBCL cells exhibit higher PD-L1 levels and capacity to secrete IL-10, resembling Breg-like features. As a result, a complex immunosuppressive microenvironment is established where DLBCL cells sustain proliferation and survival by impairing regulatory control of TFR cells and limiting IL-21-mediated anti-tumour functions of TFH cells and maximize the use of PD-1/PD-L1 signaling to escape from CD8+ cytotoxic activity. Integration of these molecular and cellular addictions into a framework may contribute to the better understanding of the lymphoma microenvironment and contribute to the rationale for novel PD-1/PD-L1-based combinational immunotherapies in DLBCL.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.3390/cancers13184683

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Centre for Human Genetics
Role:
Author
ORCID:
0000-0003-0614-8682
More by this author
Role:
Author
ORCID:
0000-0002-0687-0053
More by this author
Role:
Author
ORCID:
0000-0003-1095-0715


More from this funder
Funder identifier:
https://ror.org/025qq4838
Grant:
34E/2020


Publisher:
MDPI
Journal:
Cancers More from this journal
Volume:
13
Issue:
18
Article number:
4683
Place of publication:
Switzerland
Publication date:
2021-09-18
Acceptance date:
2021-09-13
DOI:
EISSN:
2072-6694
Pmid:
34572910


Language:
English
Keywords:
Subtype:
Review
Pubs id:
2119627
Local pid:
pubs:2119627
Deposit date:
2025-04-24
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP